Clinical trial
DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study
NCT01321073 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Active, not recruiting
Key facts
| NCT number | NCT01321073 |
|---|---|
| Title | DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study |
| Official title | DelIVery for Pulmonary Arterial Hypertension (PAH) Clinical Study |
| Acronym | DelIVery |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Collaborators | United Therapeutics Industry |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Pulmonary Arterial Hypertension |
| Intervention type | Device |
| Interventions | Model 10642 Implantable Intravascular Catheter |
| Enrollment | 64 |
| Start date | Jun 1, 2011 |
| Primary completion | Jun 1, 2013 |
| Completion | Dec 1, 2032 |
| First posted | Mar 23, 2011 |
| Last update posted | Jan 26, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: